Overview

An Exploratory Clinical Study on Neoadjuvant Treatment of Hepatocellular Carcinoma with QL1706 Combined with Lenvatinib

Status:
NOT_YET_RECRUITING

Trial end date:
2028-09-30

Target enrollment:

Participant gender:

Summary

This is a single-center, single-arm, prospective trial to explore the efficacy and safety of neoadjuvant treatment with Iparomlimab and Tuvonralimab Injection combined with lenvatinib in patients with advanced HCC

Phase:

PHASE2

Details

Lead Sponsor:

Northern Jiangsu People's Hospital

Treatments:

lenvatinib